Skip to main content

October 2025

Work as Respi CoE Analyst at Cipla

Perform part method validation, forced degradation studies, excipient compatibility studies, reverse engineering, add-mixture studies, in-use studies, hold-time study and analysis of routine & stability studies
Lilly looking for QA Principal Associate
Bachelor of Science in a science-related field such as Pharmacy, Chemistry, Biological Sciences or related Life Sciences.
Work as R&D Global Supply Study Support at Sanofi
Bachelors degree required advanced degree preferred, scientific discipline preferred with at least 2 years of operational experience in pharmaceutical production, Supply Chain, Quality and/or clinical trials.
Zentiva looking for Quality Management System Executive
Trigger out of specification investigations upon detection of test results outside predefined specifications. Design and execute tests to confirm or rule out suspected root causes.
New drug combination offers hope for men with advanced prostate cancer
A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL researchers.
New discovery finds gene converts insulin-producing cells into blood-sugar boosters
Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other life-threatening illnesses, have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 diabetes (T2D) by converting pancreatic cells that normally produce insulin into those that increase blood sugar.
Tiny Particles and Vinegar May Help Kill Superbugs, Say Scientists
A new study has found that a simple kitchen ingredient — vinegar — can become a powerful germ killer when mixed with special microscopic particles. Scientists have discovered that this new combination could help fight dangerous bacteria that no longer respond to regular antibiotics.
Eli Lilly announces USD 1 Billion investment in India
Global pharmaceutical giant Eli Lilly and Company has announced plans to invest over USD 1 billion in India to expand its manufacturing capabilities and strengthen its presence in one of the world’s fastest-growing healthcare markets.
Wockhardt Submits New Drug Application to USFDA for Zidebactam-Cefepime
Wockhardt announced the submission of New Drug Application (NDA) to the U.S. Food and Drug Administration (US FDA) for its novel antibacterial agent Zidebactam-Cefepime injection
Career for M.Pharm candidates (07 posts) in Center of Excellence at NIPER
M.Pharm in Pharmaceutical Sciences with first division from a recognized institute/university. 5-10 years of experience in pharmaceutical industry in formulation development and characterization.